Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.12
Previous CloseN/A
Volume167.40K
Average Volume (3M)3.02M
Market Cap
AU$43.64M
Enterprise ValueAU$29.57M
Total Cash (Recent Filing)AU$3.14M
Total Debt (Recent Filing)AU$6.48M
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding752,436,800
10 Day Avg. Volume2,236,112
30 Day Avg. Volume3,021,840
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)4.98
Price to Sales (P/S)1.62
P/FCF Ratio-2.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.06Price Target Upside100.00% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$22.96M
Bulls Say, Bears Say
Bulls Say
Proprietary Compact X-ray PlatformThe proprietary cold cathode platform gives Micro-X a defined technology foundation across imaging products. Its potential size, weight and power advantages are relevant to portable medical and security applications, supporting durable differentiation if customers continue adopting compact systems.
Long-term Revenue ScalingRevenue has expanded materially over the five-year period, showing that Micro-X has increased commercial scale despite an uneven recent trajectory. A larger installed and customer base can provide a foundation for future product sales, OEM activity and service revenue.
Diversified Revenue ModelMicro-X can monetize its technology through complete systems, OEM components or licensing, funded development and recurring support. This multi-channel model offers several routes to commercialize the same core capability and reduces reliance on only one product format or customer transaction.
Bears Say
Persistent UnprofitabilityThe company remains far from break-even, with losses large relative to sales and unstable gross profitability. This weak earnings base limits internally funded investment, makes operating performance sensitive to cost changes, and leaves future growth dependent on achieving substantial margin improvement.
Sustained Cash BurnRepeated negative operating and free cash flow indicates that the business is not yet funding operations and investment from internally generated cash. Continued burn can consume financial resources and increase reliance on external funding or available balance-sheet capacity over the coming periods.
Shrinking Equity And Rising LeverageA sharply reduced equity base alongside higher debt-to-equity has weakened financial flexibility. Although absolute debt is described as not yet over-levered, continued losses would leave less capital to absorb setbacks and heighten funding and potential dilution risk.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.01 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$43.64M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Feb 26, 2027 which is in 126 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Aug 27, 2026. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of AU$0 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 752,436,800 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of AU$0. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.06 (100.00% Upside)
AU$0.06 (100.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 100%
Sector Average 66%
Sector Average 66%
Insider Transactions
Bought Shares
Worth AU$38.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-47.27%
12-Months-Change
Fundamentals
Return on Equity
-188.06%
Trailing 12-Months
Asset Growth
-10.81%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions. The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.06
▲(100.00% Upside)
Technical Analysis
Compumedics Limited
―
Cyclopharm Limited
―
EMvision Medical Devices Ltd.
―
4DMedical Ltd
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―